Montana § 33-32-222 Prohibition On Prior Authorization Requirements For Prescriptions Written At Discharge From Inpatient Care

Montana Statutes

§ 33-32-222 — Prohibition On Prior Authorization Requirements For Prescriptions Written At Discharge From Inpatient Care

Montana § 33-32-222

Title 33INSURANCE AND INSURANCE COMPANIES

Ch. 32HEALTH UTILIZATION REVIEW

Part 2Utilization Review -- Conduct

This text of Montana § 33-32-222 (Prohibition On Prior Authorization Requirements For Prescriptions Written At Discharge From Inpatient Care) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 33-32-222 (2026).

Text

33-32-222 . Prohibition on prior authorization requirements for prescriptions written at discharge from inpatient care.

(1)A prescription written for an inpatient and patient under observation at the time of discharge requiring a prior authorization may not be subject to prior authorization requirements and must be immediately approved for not less than 3 days, provided that:

(a)the cost of the medication does not exceed $5,000 a day; and

(b)the physician shall note on the prescription or notify the pharmacy that the prescription is being provided at discharge.

(2)Approval beyond 3 days is subject to prior authorization review under 33-32-212 .

Free access — add to your briefcase to read the full text and ask questions with AI

33-32-222 . Prohibition on prior authorization requirements for prescriptions written at discharge from inpatient care. (1) A prescription written for an inpatient and patient under observation at the time of discharge requiring a prior authorization may not be subject to prior authorization requirements and must be immediately approved for not less than 3 days, provided that:
(a) the cost of the medication does not exceed $5,000 a day; and
(b) the physician shall note on the prescription or notify the pharmacy that the prescription is being provided at discharge.
(2) Approval beyond 3 days is subject to prior authorization review under 33-32-212 .